SCHEMBL27154645

SCHEMBL27154645

Cc1ccc(-c2nc3cc(-n4c(-c5ccc(-c6nc7ccccc7n6-c6ccc7nc(C)[nH]c7c6)cc5)nc5ccccc54)ccc3[nH]2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 4/20 0.55
▸ RAB9A P51151 4/20 0.55
▸ MEN1 O00255 3/20 0.55
▸ KMT2A Q03164 3/20 0.55
▸ SMN1; SMN2 Q16637 2/20 0.55
▸ POLB P06746 2/20 0.55
▸ CHEK2 O96017 3/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ MAPT P10636 2/20 0.43
▸ NPBWR1 P48145 2/20 0.43
▸ NFKB1 P19838 1/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ NFKB2 Q00653 1/20 0.43
▸ RELA Q04206 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ GLA P06280 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ GFER P55789 1/20 0.43
▸ RXFP1 Q9HBX9 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27154669 0.82 HDAC6 (0.52) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL23873951 0.80 ESR1 (0.56) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL23874010 0.78 ESR1 (0.46) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL23874038 0.77 HDAC6 (0.53) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL27154670 0.77 SCD (0.56) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL13287104 0.77 MEN1 (0.68) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL34856 0.77 MEN1 (0.68) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL13041694 0.77 MEN1 (0.68) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL26357001 0.74 NPC1 (0.67) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL12864579 0.74 NPC1 (0.57) NPC1RAB9AMEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11912825-B2 Polymers derived from 2,2′-bisimidazoles THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) 2024-02-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11912825-B2 Polymers derived from 2,2′-bisimidazoles PARG, PARN, NOP2 NPC1 4205/4885RAB9A 3657/4885MEN1 2984/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback